MARSHALL KEITH W (Chief Financial Officer) sold 33.8% of their position (5K shares) of PROMETHEUS BIOSCIENCES, INC. on the open market
Open‑market sale worth $596.9K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/17/2023ACC: 0001209191-23-010974
Officer· Chief Financial Officer
Since Mar 2021
-5K
Net shares
Net seller
$596.9K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 10K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$3.70
Trade value
$18.50K
% of position
51.0%
2/15/2023
9.81K→14.81K
Common Stock
Direct
Shares
−5K
Price / share
$119.38
Trade value
$596.90K
% of position
33.8%
2/15/2023
14.81K→9.81K
Total
Net shares
+0.00
Net value
-$578.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2023 | M · Option Exercise | +5K | $3.70 | $18.50K | 51.0% | 9.81K | 14.81K |
| Common Stock Direct | 2/15/2023 | S · Sale | −5K | $119.38 | $596.90K | 33.8% | 14.81K | 9.81K |
| Total | +0.00 | -$578.40K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
3.70
Held after
113.04K
Exercisable
—
2/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 2/15/2023 | M · Option Exercise | −5K | 3.70 | — | 113.04K |